vs

Side-by-side financial comparison of Array Technologies, Inc. (ARRY) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

Array Technologies, Inc. is the larger business by last-quarter revenue ($226.0M vs $209.8M, roughly 1.1× MYRIAD GENETICS INC). On growth, MYRIAD GENETICS INC posted the faster year-over-year revenue change (-0.4% vs -17.9%). Over the past eight quarters, Array Technologies, Inc.'s revenue compounded faster (21.4% CAGR vs 1.9%).

ATI Technologies Inc. was a Canadian semiconductor technology corporation based in Markham, Ontario, that specialized in the development of graphics processing units and chipsets. Founded in 1985, the company listed publicly in 1993 and was acquired by AMD in 2006. As a major fabless semiconductor company, ATI conducted research and development in-house and outsourced the manufacturing and assembly of its products. With the decline and eventual bankruptcy of 3dfx in 2000, ATI and its chief ri...

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

ARRY vs MYGN — Head-to-Head

Bigger by revenue
ARRY
ARRY
1.1× larger
ARRY
$226.0M
$209.8M
MYGN
Growing faster (revenue YoY)
MYGN
MYGN
+17.5% gap
MYGN
-0.4%
-17.9%
ARRY
Faster 2-yr revenue CAGR
ARRY
ARRY
Annualised
ARRY
21.4%
1.9%
MYGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARRY
ARRY
MYGN
MYGN
Revenue
$226.0M
$209.8M
Net Profit
Gross Margin
8.6%
70.0%
Operating Margin
-65.5%
-2.7%
Net Margin
Revenue YoY
-17.9%
-0.4%
Net Profit YoY
EPS (diluted)
$-1.06
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARRY
ARRY
MYGN
MYGN
Q4 25
$226.0M
$209.8M
Q3 25
$393.5M
$205.7M
Q2 25
$362.2M
$213.1M
Q1 25
$302.4M
$195.9M
Q4 24
$275.2M
$210.6M
Q3 24
$231.4M
$213.3M
Q2 24
$255.8M
$211.5M
Q1 24
$153.4M
$202.2M
Net Profit
ARRY
ARRY
MYGN
MYGN
Q4 25
Q3 25
$33.5M
$-27.4M
Q2 25
$43.3M
$-330.5M
Q1 25
$16.7M
$-100.0K
Q4 24
Q3 24
$-141.4M
$-22.1M
Q2 24
$25.7M
$-36.7M
Q1 24
$2.2M
$-26.0M
Gross Margin
ARRY
ARRY
MYGN
MYGN
Q4 25
8.6%
70.0%
Q3 25
26.9%
69.9%
Q2 25
26.8%
71.2%
Q1 25
25.3%
68.5%
Q4 24
28.5%
71.7%
Q3 24
33.8%
70.2%
Q2 24
33.6%
69.6%
Q1 24
35.9%
68.1%
Operating Margin
ARRY
ARRY
MYGN
MYGN
Q4 25
-65.5%
-2.7%
Q3 25
11.6%
-11.3%
Q2 25
12.8%
-154.5%
Q1 25
9.0%
-14.8%
Q4 24
-51.7%
-18.6%
Q3 24
-57.3%
-9.4%
Q2 24
15.5%
-17.3%
Q1 24
5.5%
-13.8%
Net Margin
ARRY
ARRY
MYGN
MYGN
Q4 25
Q3 25
8.5%
-13.3%
Q2 25
11.9%
-155.1%
Q1 25
5.5%
-0.1%
Q4 24
Q3 24
-61.1%
-10.4%
Q2 24
10.0%
-17.4%
Q1 24
1.4%
-12.9%
EPS (diluted)
ARRY
ARRY
MYGN
MYGN
Q4 25
$-1.06
$-0.09
Q3 25
$0.12
$-0.29
Q2 25
$0.19
$-3.57
Q1 25
$0.02
$0.00
Q4 24
$-0.94
$-0.47
Q3 24
$-1.02
$-0.24
Q2 24
$0.08
$-0.41
Q1 24
$-0.07
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARRY
ARRY
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$244.4M
$149.6M
Total DebtLower is stronger
$119.9M
Stockholders' EquityBook value
$-206.3M
$368.0M
Total Assets
$1.5B
$706.6M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARRY
ARRY
MYGN
MYGN
Q4 25
$244.4M
$149.6M
Q3 25
$221.5M
$145.4M
Q2 25
$377.3M
$74.4M
Q1 25
$348.3M
$91.8M
Q4 24
$363.0M
$102.4M
Q3 24
$332.4M
$99.9M
Q2 24
$282.3M
$97.3M
Q1 24
$287.6M
$104.3M
Total Debt
ARRY
ARRY
MYGN
MYGN
Q4 25
$119.9M
Q3 25
$119.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ARRY
ARRY
MYGN
MYGN
Q4 25
$-206.3M
$368.0M
Q3 25
$-46.7M
$372.8M
Q2 25
$-70.9M
$388.1M
Q1 25
$-97.8M
$704.9M
Q4 24
$-118.1M
$701.1M
Q3 24
$64.5M
$731.7M
Q2 24
$200.0M
$740.5M
Q1 24
$231.2M
$760.0M
Total Assets
ARRY
ARRY
MYGN
MYGN
Q4 25
$1.5B
$706.6M
Q3 25
$1.6B
$728.1M
Q2 25
$1.5B
$677.3M
Q1 25
$1.4B
$1.0B
Q4 24
$1.4B
$1.0B
Q3 24
$1.6B
$1.1B
Q2 24
$1.7B
$1.1B
Q1 24
$1.6B
$1.1B
Debt / Equity
ARRY
ARRY
MYGN
MYGN
Q4 25
0.33×
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARRY
ARRY
MYGN
MYGN
Operating Cash FlowLast quarter
$43.6M
$10.6M
Free Cash FlowOCF − Capex
$36.2M
FCF MarginFCF / Revenue
16.0%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$79.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARRY
ARRY
MYGN
MYGN
Q4 25
$43.6M
$10.6M
Q3 25
$27.4M
$21.1M
Q2 25
$43.8M
$-13.6M
Q1 25
$-13.1M
$-16.3M
Q4 24
$57.6M
$6.6M
Q3 24
$44.9M
$700.0K
Q2 24
$4.0M
$2.6M
Q1 24
$47.5M
$-18.6M
Free Cash Flow
ARRY
ARRY
MYGN
MYGN
Q4 25
$36.2M
Q3 25
$21.9M
Q2 25
$37.2M
Q1 25
$-15.4M
Q4 24
$55.9M
Q3 24
$43.9M
Q2 24
$1.8M
Q1 24
$45.1M
FCF Margin
ARRY
ARRY
MYGN
MYGN
Q4 25
16.0%
Q3 25
5.6%
Q2 25
10.3%
Q1 25
-5.1%
Q4 24
20.3%
Q3 24
19.0%
Q2 24
0.7%
Q1 24
29.4%
Capex Intensity
ARRY
ARRY
MYGN
MYGN
Q4 25
3.3%
Q3 25
1.4%
Q2 25
1.8%
Q1 25
0.8%
Q4 24
0.6%
Q3 24
0.5%
Q2 24
0.8%
Q1 24
1.6%
Cash Conversion
ARRY
ARRY
MYGN
MYGN
Q4 25
Q3 25
0.82×
Q2 25
1.01×
Q1 25
-0.78×
Q4 24
Q3 24
Q2 24
0.15×
Q1 24
21.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARRY
ARRY

Array Legacy Operations Segment$212.0M94%
STI Operations Segment$14.0M6%

MYGN
MYGN

Segment breakdown not available.

Related Comparisons